With a history of +75 years, Olyos Group is an international scalable growth platform in Natural & Health nutrition with €200m in Sales, distributed in Pharmacies & Parapharmacies and online.

Olyos Group distinguishes itself as a multi-regional growth platform at the forefront of innovation that relies on strong local brands built around strong values (naturalness & performance) and backed by a scientifical and pharmaceutical approach.

Olyos Group’s strategy is supported by 3 main pillars: its organic growth, the consolidation of the European food supplement market and operational excellence with a focus on ESG. The Group has a demonstrated track record of buy&build, with 8 acquisitions realized over the past few years to expand its geographical footprint across Europe and Latin America.

Olyos is today the number 1 growth performer of the market, has established itself as a key reference partner for pharmacies and has developed a strong e-commerce presence.

It operates two main production sites in Annemasse (France) and Leon (Spain) and counts more than 600 employees, led by Thierry Verne and Jonathan Bienfait.

After a first phase of investment between 2017 et 2025 during which Motion Equity Partners supported Olyos Group in the ambition to build one of the most sizeable European players in the health nutrition, Motion Equity Partners reinvested a majority stake in June 2025 through a dedicated fund. The ambition is to support Olyos’ next phase of growth (notably the further deployment of its successful commercial model in pharmacy and online channels) and the acceleration of its ambitious external growth strategy, both in France and internationally. The Continuation Fund has been sized to anticipate and finance future build-up opportunities.